Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC)
Clinical trial NCT02400788 · COMPLETED
Trial details
- NCT number
- NCT02400788
- Sponsor
- Yakult Honsha Co., LTD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2016-06-01
- Enrollment
- 179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.